Dr. Thomas Earl, MD (he/him) is a Cardiologist, Interventional Cardiologist, Internist in Bangor, ME with over 17 years of experience. What is your opinion of Dr. Thomas Earl, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 17 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Thomas Earl, MD has received over $13,496 which includes payments from the following companies:
$3,584.50 from Edwards Lifesciences Corporation
$2,137.74 from Abbott Laboratories
$1,696.24 from Boston Scientific Corporation
$1,605.85 from Medtronic Vascular, Inc.
$1,169.92 from The Spectranetics Corporation
$1,130.02 from ABIOMED
$902.76 from Cardiac Assist, Inc.
$214.87 from Cardiovascular Systems Inc.
$161.95 from Cardinal Health 200, LLC
$151.32 from AstraZeneca Pharmaceuticals LP
$137.93 from Siemens Medical Solutions USA, Inc.
$114.53 from Penumbra, Inc.
$104.32 from ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$93.15 from St. Jude Medical, Inc.
$88.53 from Novartis Pharmaceuticals Corporation
$71.05 from E.R. Squibb & Sons, L.L.C.
$51.98 from Corindus Inc.
$31.65 from Regeneron Healthcare Solutions, Inc.
$18.93 from Janssen Pharmaceuticals, Inc
$16.40 from EKOS Corporation
Payments received by Dr. Thomas Earl, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!